Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation

Transplantation Proceedings

Volumn 33, Issue 7-8, 2001, Pages 3637-3638

  Rosenau, J ^a   Tillmann, H L ^a   Bahr, M J ^a   Trautwein, C ^a   Boeker, K H W ^a   Nashan, B ^a   Klempnauer, J ^a   Manns, M P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; LAMIVUDINE; VIRUS DNA;

ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FOLLOW UP; HEPATITIS B; HUMAN; INFECTION PREVENTION; LIVER TRANSPLANTATION; PRIORITY JOURNAL; REINFECTION; RISK FACTOR; SURVIVAL;

ANTIVIRAL AGENTS; DNA, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; LAMIVUDINE; LIVER TRANSPLANTATION; RECURRENCE;

EID: 0035674751     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)02564-7     Document Type: Article

References (5)

1. Samuel D, Müller R, Alexander G, et al: N Engl J Med 329:1842, 1993
2. Mutimer D, Pillay D, Dragon E, et al: J Hepatol 30:715, 1999
3. Markowitz JS, Martin P, Conrad AJ, et al: Hepatology 28:585, 1998
4. Rosenau J, Bahr MJ, Tillmann HL, et al: J Hepatol 34:895, 2001
5. Villeneuve JP, Condreay LD, Willems B, et al: Hepatology 31:207, 2000